...
SDPA Fall 2018 | Product Theater | Changing How We Treat Raised Seborrheic Keratoses (SKs)
November 3, 2018

Dr. Fran Cook-Bolden presented Changing How We Treat Raised Seborrheic Keratosis (SKs) at the 16th Annual Fall Dermatology Conference. In this lecture, she presented the first and only FDA-approved topical treatment for raised SKs. Dr. Cook-Bolden highlighted that SKs can develop anywhere on the body excluding the palms, soles, and mucous membranes, and typically appear

...
SDPA Fall 2018 | Product Theater | Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis

At the first product theater on day 3 of the 16th Annual Fall Dermatology Conference, Dr. Firas Hougeir shared his extensive knowledge and experience in the treatment of patients with psoriasis with his lecture entitled Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis. Dr. Hougeir started his lecture

...
SDPA Fall 2018 | Walking Tour of the 2018 Abstracts

The sun in Orlando is bright and the weather is clear and cooler on the third full day of SDPA’s 16th Annual Fall Dermatology Conference. This morning Dr. Mark Russell led a Walking Tour of the 2018 Abstracts. He walked with a group of SDPA members as they viewed the posters presented in the Tuscan

...
SDPA Fall 2018 | Dupixent (dupilumab)

On day two of the 16th Annual Fall Conference, Cynthia Trickett, MPAS, PA-C, DFAAPA shared her clinical insights regarding the treatment of atopic dermatitis (AD) in her lecture on Dupixent. AD is estimated to affect 3.2% of adults in the US and around 1.6 million with moderate to severe AD remain uncontrolled despite treatment. Ms.

...
SDPA Fall 2018 | What’s New in Biologics

On Friday November 2, the second full day of SDPA’s 16th Annual Fall Dermatology Conference Dr. Misha Rosenbach spoke about What’s New in Biologics. Many of the topics he discussed included off label use since indications are still limited. His specialty is granulomatous and neutrophilic diseases and he has used biologic therapy for such conditions

...
SDPA Fall 2018 | Product Theater | The Evolution of Topical Rosacea Treatment
November 2, 2018

In the second product theater on the first day of the general conference, Dr. Jeffery Fromowitz shared his clinical experience treating rosacea with topical products. Dr. Fromowitz highlighted that rosacea is a chronic inflammatory disease that affects approximately 16 million Americans and can occur in any race or ethnic background. In addition, rosacea can adversely